| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Enliven Therapeutics, Inc. (ELVN) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 15 sells. ELVN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 890.4K | $42.82M | - | |
| CEO | 875.0K | $42.08M | - | |
| Other | 740.2K | $35.60M | - | |
| 10% | 245.7K | $11.82M | -281,408 | |
| COO | 215.0K | $10.34M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 6, 2024 | Patel Anish54 | Chief Operating Officer | Sale+OE | 4,875 | $22.72 | $110,769.26 | -100% | -3.5% | -14.1% | |
| May 3, 2024 | Hohl Benjamin60 | Chief Financial Officer | Sale+OE | 1,000 | $22.50 | $22,500.00 | -100% | +9.1% | -9.4% | |
| Apr 29, 2024 | Lyssikatos Joseph P50 | Chief Scientific Officer | Sale+OE | 12,000 | $17.92 | $214,987.75 | -92.2% | +49.3% | +4.8% | |
| Apr 29, 2024 | Hohl Benjamin60 | Chief Financial Officer | Sale+OE | 3,250 | $16.97 | $55,164.53 | -100% | +49.3% | +4.8% | |
| Apr 25, 2024 | Kintz Samuel51 | President And CEO | Sale+OE | 12,000 | $16.89 | $202,700.40 | -100% | +43.1% | +8.5% | |
| Apr 15, 2024 | Heyman Richard A.74 | Director | Sell | 6,964 | $24.11 | $167,887.52 | -2.2% | +25.9% | -14.5% | |
| Apr 11, 2024 | Collins Helen Louise63 | Chief Medical Officer | Sale+OE | 20,000 | $25.07 | $501,478.00 | -100% | -3.2% | -30.7% | |
| Apr 11, 2024 | Kintz Samuel51 | President And CEO | Sale+OE | 47,709 | $25.04 | $1,194,700.15 | -100% | -3.2% | -30.7% | |
| Apr 11, 2024 | Hohl Benjamin60 | Chief Financial Officer | Sale+OE | 14,000 | $24.72 | $346,148.88 | -57.8% | -3.2% | -30.7% | |
| Apr 11, 2024 | Patel Anish54 | Chief Operating Officer | Sale+OE | 17,500 | $25.03 | $438,098.50 | -100% | -3.2% | -30.7% |